SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
August 18, 2025
 · 
4 min read
Press Releases
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
August 18, 2025
 · 
15 min read
Press Releases
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
August 18, 2025
 · 
1 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
3 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
1 min read
Press Releases
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
 · 
3 min read
Press Releases
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
August 18, 2025
 · 
11 min read
Press Releases
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
August 18, 2025
 · 
3 min read
Press Releases
Gabby Thomas Partners with Babson Diagnostics’ BetterWay to Promote Accessible Healthcare
Olympic Gold Medalist and Public Health Advocate to Raise Awareness for Routine Blood Testing
August 15, 2025
 · 
1 min read
Press Releases
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025
 · 
2 min read
Press Releases
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
August 15, 2025
 · 
11 min read
Press Releases
Novel Gene Therapy for ALS cleared for global trials in China and the U.S.
August 15, 2025
 · 
4 min read
Press Releases
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
 · 
14 min read
Press Releases
Santhera extends Highbridge convertible bond to 30th September 2025
August 15, 2025
 · 
2 min read
Press Releases
BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth.
August 15, 2025
 · 
6 min read
Press Releases
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
August 15, 2025
 · 
1 min read
Press Releases
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
August 15, 2025
 · 
3 min read
Press Releases
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
August 15, 2025
 · 
3 min read
Press Releases
Encision Reports First Quarter Fiscal Year 2026 Results
August 15, 2025
 · 
5 min read
Press Releases
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 15, 2025
 · 
10 min read
Press Releases
HLS Therapeutics Announces Q2 2025 Financial Results
August 15, 2025
 · 
17 min read
Press Releases
Landmark Clinical Study Published in Spine Demonstrates Superiority of Tissue-Sparing Circumferential Cervical Fusion Over ACDF Alone in Multilevel Cervical Fusion Surgery
August 15, 2025
 · 
4 min read
Press Releases
Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 15, 2025
 · 
12 min read
Press Releases
EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation
August 15, 2025
 · 
2 min read
Press Releases
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
August 19, 2025
 · 
9 min read
Press Releases
Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
August 19, 2025
 · 
4 min read
Press Releases
NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib
August 19, 2025
 · 
12 min read
Press Releases
Ultragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
August 19, 2025
 · 
6 min read
Press Releases
Catheter Precision Receives Approval for LockeT in the United Kingdom
August 19, 2025
 · 
3 min read
Press Releases
OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer
August 19, 2025
 · 
3 min read
Press Releases
Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
August 19, 2025
 · 
8 min read
Press Releases
A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials
August 19, 2025
 · 
8 min read
Press Releases
Accord BioPharma Announces Commercial Launch of IMULDOSA® (ustekinumab-srlf) Prefilled Syringes at Lowest WAC Price Among Branded Biosimilars to STELARA® (ustekinumab)
August 19, 2025
 · 
12 min read
Press Releases
Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
August 19, 2025
 · 
3 min read
Load More